Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
WuXi Bio provided technical services, based on the companies' versatile integrated service platforms, to support various manufacturing and process development activities of these ADC product candidates.
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
The order marks a significant milestone for MMP Industries that will contribute to the company's revenue in the coming financial year
The facility is over 79,000 square feet and is equipped with packaging lines
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
Time to combine innovation, access and technology to deliver positive patient outcomes
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
